AI Summary
In this study, researchers developed nitric oxide releasing oxoisoporphines that exhibit antidepressant activities. These compounds were found to regulate both the MAO-A enzyme and the SERT protein, providing a novel approach to treating depression. The use of nitric oxide in conjunction with these alkaloids represents a promising avenue for further research in the development of new antidepressant medications.